Profilo
Michael Broxson is currently a Director at Molecular Templates OpCo, Inc. and a Vice President, Head-Research & Development at Takeda Pharmaceuticals U.S.A., Inc. He was previously the Chief Executive Officer at Q32 Bio, Inc. and a Director at Molecular Templates, Inc. Broxson received an undergraduate degree from Tulane University (Louisiana) and an MBA degree from The University of Chicago Booth School of Business.
Posizioni attive di Michael Broxson
| Società | Posizione | Inizio |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Direttore Tecnico/Scientifico/R&S | - |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michael Broxson
| Società | Posizione | Fine |
|---|---|---|
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Amministratore Delegato | 20/09/2022 |
| MOLECULAR TEMPLATES, INC. | Direttore/Membro del Consiglio | - |
Formazione di Michael Broxson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc.
Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
















